Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Lung Cancer. 2015 Apr 9;89(1):43–49. doi: 10.1016/j.lungcan.2015.03.023

Table 1.

Patient and tumor characteristics

Variables N Percentage (%)
All Patients 328 100
Gender
 Male 156 47.6
 Female 172 52.4
TNM Stage
 Stage IA/IB 46/43 14.0/13.1
 Stage IIA/IIB 19/18 5.8/5.5
 Stage IIIA/IIIB 52/39 15.9/11.9
 Stage IV 111 33.8
Histology
 Adenocarcinoma 129 39.3
 Squamous cell carcinoma 92 28.0
 Large cell carcinoma 21 6.4
 Not otherwise specified 78 23.8
 Others 8 2.4
Treatment*
 No cancer specific therapy 37 11.3
 No surgery with chemo/XRT 180 54.9
  Chemo only 55
  XRT only 28
  Both 97
 Surgery 111 33.8
Age (years: mean±SD, median [range]) 67.5±10.5, 68.3 [30.0–89.9]
MTVWB(ml: mean±SD, median [range]) 149.57±221.29, 66.33 [1.04–1566.88]

Notes: N = number of patients; others = other types of non-small cell lung cancer; Chemo/XRT = chemoradiation; SD = standard deviation; MTVWB = whole-body metabolic tumor volume.

*

Surgery was always performed with curative intent, but the intent of non-surgical treatment was unknown.